These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21038163)

  • 1. Cognitive and motor control in neurofibromatosis type I: influence of maturation and hyperactivity-inattention.
    Huijbregts S; Swaab H; de Sonneville L
    Dev Neuropsychol; 2010; 35(6):737-51. PubMed ID: 21038163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early grade repetition and inattention associated with neurofibromatosis type 1.
    Coudé FX; Mignot C; Lyonnet S; Munnich A
    J Atten Disord; 2007 Sep; 11(2):101-5. PubMed ID: 17494836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive control in adolescents with neurofibromatosis type 1.
    Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
    Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using a Virtual Classroom environment to describe the attention deficits profile of children with Neurofibromatosis type 1.
    Gilboa Y; Rosenblum S; Fattal-Valevski A; Toledano-Alhadef H; Rizzo AS; Josman N
    Res Dev Disabil; 2011; 32(6):2608-13. PubMed ID: 21757320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The self-concept of children and adolescents with neurofibromatosis type 1.
    Barton B; North K
    Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time reproduction, working memory, and behavioral inhibition in children with ADHD.
    Kerns KA; McInerney RJ; Wilde NJ
    Child Neuropsychol; 2001 Mar; 7(1):21-31. PubMed ID: 11815878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.
    Lidzba K; Granström S; Lindenau J; Mautner VF
    Dev Med Child Neurol; 2012 Oct; 54(10):892-7. PubMed ID: 22881119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory capacity in adults with symptoms of Attention Deficit/Hyperactivity Disorder (ADHD).
    Wodushek TR; Neumann CS
    Arch Clin Neuropsychol; 2003 Apr; 18(3):317-30. PubMed ID: 14591462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
    Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
    J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of self-regulation and inhibition in children exhibiting attention deficit disorder with or without hyperactivity (ADHD)].
    Poissant H; Neault I; Dallaire S; Rouillard M; Emond V; Guay MC; Lageix P
    Encephale; 2008 Apr; 34(2):161-9. PubMed ID: 18597724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings.
    Erdoğan-Bakar E; Cinbiş M; Ozyürek H; Kiriş N; Altunbaşak S; Anlar B
    Turk J Pediatr; 2009; 51(6):565-71. PubMed ID: 20196390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)?
    Galasso C; Lo-Castro A; Di Carlo L; Pitzianti MB; D'Agati E; Curatolo P; Pasini A
    J Child Neurol; 2014 Oct; 29(10):1320-6. PubMed ID: 24532810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive function in attention-deficit-hyperactivity disorder with and without comorbid disruptive behaviour disorders.
    Barnett R; Maruff P; Vance A
    Aust N Z J Psychiatry; 2009 Aug; 43(8):722-30. PubMed ID: 19629793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive functioning among Finnish adolescents with attention-deficit/hyperactivity disorder.
    Loo SK; Humphrey LA; Tapio T; Moilanen IK; McGough JJ; McCracken JT; Yang MH; Dang J; Taanila A; Ebeling H; Järvelin MR; Smalley SL
    J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1594-604. PubMed ID: 18030081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.